Later this week, our CEO Christian Groendahl will open Day 2 of the JAFRAL Phage Summit 2026 in Ljubljana as keynote speaker. The talk will focus on how engineered phage-based therapies are moving from laboratory promise toward clinical reality.

We're hiring a Senior Project Manager with a solid project management toolbox and strong microbiology/bacteriology expertise to help drive key research projects forward in our mission to defeat antimicrobial resistance with CRISPR-powered medicines, details: blackswansexist.com/job/senior-p...

Last month, Christian Grøndahl and I joined @carb-x.bsky.social Investor Day in Munich ahead of @escmid.bsky.social Global. Always energizing to be among so many teams pushing #AMR innovation forward; from early discovery to clinical-stage programs and showcase @sniprbiome.com SNIPR001

We're hiring a Laboratory Technician to join our Preclinical Testing team in Copenhagen: hands-on work with bacteria, phages, and CRISPR-based medicines. 1-year position, apply by May 3 www.linkedin.com/jobs/view/44...

🌍 Four events, three cities, one mission for SNIPR. We're excited to be taking our science and story across Europe over the next several days. We'd love to connect. 👋 #CRISPRMED26 #ESCMIDGlobal2026 #CRISPR @carb-x.bsky.social #SPRIND @escmid.bsky.social @sprind-de.bsky.social

We were excited to welcome the production company Nordic Made Film earlier this week to film at SNIPR and interview our CEO Christian Groendahl. The visit is part of a new documentary series, The Microbes That Save Us, highlighting how microbes and cutting-edge biotechnology.

We're at the 8th Annual Bacteriophage Summit in London this week! Tomorrow, Jonas Hink will take the stage to talk about advancing engineered phages toward clinical reality. 📅 Wednesday, 25 March | 4:00 PM

Today, we're excited to announce the publication of the final positive Phase 1 results for SNIPR001, our CRISPR therapeutic designed to precisely reduce E. coli in the gut — including multi-drug resistant strains — while preserving healthy gut bacteria in @lancetmicrobe.bsky.social

We’re excited to share real-world lessons from building and translating CRISPR-based antimicrobials - what’s worked, what hasn’t, and what it takes to move from promise to patient impact at the 10th AMR Conference. Come meet @evdh.bsky.social in Basel. @incate.bsky.social

We’re starting the new year fresh with a brand-new website. Take a look and let us know what you think: www.sniprbiome.com

Job opening: Research Assistant Are you a skilled scientist early in your career with a passion for bacterial strain engineering and an interest in supporting projects across our research organization? Apply before the 20th of January here: www.linkedin.com/jobs/view/43...

Proud moment for all of us at SNIPR; we’ve just published our research on a novel CRISPR–Cas system.

SNIPR will be in San Francisco for the 44th annual #JPM2026 conference in January. Christian Groendahl and @evdh.bsky.social will be involved in JPM week events - reach out if you’d like to meet while in town.

Heading to London for the ⁦‪Jefferies‬⁩ Global Healthcare Conference Nov 17–20. ⁦‪@sniprbiome.com‬⁩ will be on-site, together w. ⁦‪ Christian Groendahl‬⁩. We’re excited to share insights on our proprietary CRISPR platform and our differentiated #AMR pipeline. #JefferiesHealthcare

We are pleased to announce two important promotions within our leadership team. Jonas Hink has been appointed as Chief Medical Officer. Christian Mygind has been appointed as Chief Financial Officer. Please join us in congratulating them on these well-deserved appointments.

In Gothenburg next week for Nordic Life Science Days. Attending too? Reach out to @evdh.bsky.social for a quick chat. #NLSDays2025

Next week, on Thursday 18 September, Jonas Eegholm will present SNIPR BIOME’s poster in Heidelberg at the @embo.org | @embl.org Symposium – The human microbiome titled “Characterisation and functionalization of a type IV #CRISPR-Cas system for bacterial engineering.”

Our CEO, Christian Groendahl, will be presenting at the 83rd International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences in Copenhagen, in the session LSMO-01: Novel antimicrobials in the pipeline on Monday, 1 September 2025 from 13:00–14:00.

We proudly announced the close of a €35 million Series B financing! #AMR #CRISPR #SeriesB

New open position at SNIPR BIOME: Are you a skilled Laboratory Technician that can drive and maintain our laboratory and have an interest in supporting projects across our research organization? Apply here: www.linkedin.com/jobs/view/42... before June 26th

SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer— the first CRISPR-armed phage therapeutic designed to target E. coli in the gut. @carb-x.bsky.social Read the full press release in the link below 👇

Looking forward to meeting at #BIO2025! Reach out if you'd like to connect with Christian Groendahl and me in Boston June 16-19. DM here or email [email protected]. @sniprbiome.com

We are hiring for two key roles in our growing SNIPR BIOME team in Copenhagen. We are looking for: - Bioinformatician / Data Scientist lnkd.in/dp_GAHRY - Research Assistant in Phage Engineering lnkd.in/dXER77Hj

Join the SNIPR Biome - A CRISPR Company Team in Copenhagen🇩🇰! We're hiring a Bioinformatician/Data Scientist passionate about bacterial genomics and microbiome science. Deadline is already in two weeks. www.linkedin.com/jobs/view/42...

This week, our Director of Bacterial Engineering Szabolcs Semsey will present a poster on the latest CRISPR-Cas systems at the Gordon Research Conferences on Bacterial Cell Biology and Development, held at Southern New Hampshire University.

Christian Groendahl and @evdh.bsky.social will be attending next week's #BioEquity in Bruges🇧🇪. Reach out to learn more about our recent progress and updates of our pipeline. #partnering #BioEquityEurope

Meet SNIPR BIOME next week: Jakob & @evdh.bsky.social at Venture @sprind-en.bsky.social Berlin (Apr 8), Alice discussing untreatable infections at EU Parliament, and Christian & Anders at @escmid.bsky.social Vienna (Apr 10-14). Don't miss our SNIPR001 poster (P2537) Apr 13, 12:00–13:30, Hall D!

Next week, Christian Groendahl and @evdh.bsky.social will be attending #BIOEuropeSpring in Milan. Looking forward to sharing updates on SNIPR Biome’s exciting CRISPR technology pipeline. If you'll be there, please reach out via [email protected]. We look forward to connecting!

Pleased to participate yesterday in the #HERAInfoDay in Copenhagen. Our CEO and co-founder Christian Groendahl, presented on how critical funding from the European Health Emergency Preparedness and Response Authority (#HERA) and @eib.org has significantly advanced SNIPR001

Our Director of Preclinical Testing, Aurelie Gram, will join the first Microbiome Times Partnering Forum in Brussels later this month to discuss the development of CRISPR-Cas therapeutic SNIPR001. Registration link in the comments

SNIPR Biome strengthens IP portfolio with a patent granted for a novel #CRISPR-Cas system! Read more in the press release below.

We are looking for an early career Research Assistant @sniprbiome.com to develop new medicines within infectious and metabolic diseases. Application deadline is 10th February 2025 www.linkedin.com/jobs/view/41...